Tilray Subsidiary FL Group Partners with Molteni to Enhance Medical Cannabis Access in Italy

Reuters2025-08-13

Tilray Subsidiary FL Group Partners with Molteni to Enhance Medical Cannabis Access in Italy

Tilray Medical, a division of Tilray Brands, Inc., has announced a strategic partnership through its wholly-owned subsidiary, FL Group S.R.L., with L. Molteni & C. dei F.lli Alitti Società di Esercizio S.p.A., an Italian pharmaceutical company. This collaboration aims to expand access to medical cannabis extracts across Italy. By combining FL Group's regulatory and distribution capabilities with Molteni's scientific expertise, the partnership seeks to enhance the availability of EU-GMP certified cannabis therapies. Additionally, Molteni will leverage its extensive network of healthcare professionals to provide targeted education on medical cannabis therapies, emphasizing pain management solutions. Tilray Medical continues to be a leader in the European medical cannabis market, with operations in Germany, Italy, Portugal, Poland, and the United Kingdom.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tilray Brands Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9510473-en) on August 13, 2025, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

K75
2025-08-14
K75
Great article, would you like to share it?

Leave a comment

1

1

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2559609994?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-08-13 19:00","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2559609994","market":"fut","top_or_hot":-1,"title":"Tilray Subsidiary FL Group Partners with Molteni to Enhance Medical Cannabis Access in Italy","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      Tilray Subsidiary FL Group Partners with Molteni to Enhance Medical Cannabis Access in Italy\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Tilray Medical, a division of Tilray Brands, Inc., has announced a strategic partnership through its wholly-owned subsidiary, FL Group S.R.L., with L. Molteni &amp; C. dei F.lli Alitti Società di Esercizio S.p.A., an Italian pharmaceutical company. This collaboration aims to expand access to medical cannabis extracts across Italy. By combining FL Group's regulatory and distribution capabilities with Molteni's scientific expertise, the partnership seeks to enhance the availability of EU-GMP certified cannabis therapies. Additionally, Molteni will leverage its extensive network of healthcare professionals to provide targeted education on medical cannabis therapies, emphasizing pain management solutions. Tilray Medical continues to be a leader in the European medical cannabis market, with operations in Germany, Italy, Portugal, Poland, and the United Kingdom.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tilray Brands Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9510473-en) on August 13, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tilray Subsidiary FL Group Partners with Molteni to Enhance Medical Cannabis Access in Italy</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTilray Subsidiary FL Group Partners with Molteni to Enhance Medical Cannabis Access in Italy\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-08-13 19:00</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      Tilray Subsidiary FL Group Partners with Molteni to Enhance Medical Cannabis Access in Italy\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Tilray Medical, a division of Tilray Brands, Inc., has announced a strategic partnership through its wholly-owned subsidiary, FL Group S.R.L., with L. Molteni &amp; C. dei F.lli Alitti Società di Esercizio S.p.A., an Italian pharmaceutical company. This collaboration aims to expand access to medical cannabis extracts across Italy. By combining FL Group's regulatory and distribution capabilities with Molteni's scientific expertise, the partnership seeks to enhance the availability of EU-GMP certified cannabis therapies. Additionally, Molteni will leverage its extensive network of healthcare professionals to provide targeted education on medical cannabis therapies, emphasizing pain management solutions. Tilray Medical continues to be a leader in the European medical cannabis market, with operations in Germany, Italy, Portugal, Poland, and the United Kingdom.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tilray Brands Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9510473-en) on August 13, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4547","symbol_name":"WSB热门概念","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250813:nNDL9PqKr:1","article_id":"2559609994","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2559609994","pubTimestamp":1755082841,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"Tilray Medical, a division of Tilray Brands, Inc., has announced a strategic partnership through its wholly-owned subsidiary, FL Group S.R.L., with L. Molteni & C. dei F.lli Alitti Società di Esercizio S.p.A., an Italian pharmaceutical company. This collaboration aims to expand access to medical cannabis extracts across Italy. By combining FL Group's regulatory and distribution capabilities with Molteni's scientific expertise, the partnership seeks to enhance the availability of EU-GMP certified cannabis therapies. Additionally, Molteni will leverage its extensive network of healthcare professionals to provide targeted education on medical cannabis therapies, emphasizing pain management solutions. Tilray Medical continues to be a leader in the European medical cannabis market, with operations in Germany, Italy, Portugal, Poland, and the United Kingdom.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4547":"WSB热门概念","LU0314104364.USD":"MANULIFE GF AMERICAN GROWTH \"AA\" (USD) INC","BK4585":"ETF&股票定投概念","IE00B64PRP62.GBP":"GUINNESS GLOBAL MONEY MANAGERS \"C\" (GBP) ACC","BK4596":"哈里斯概念","BK4007":"制药","LU2210149790.SGD":"Natixis Thematics Subscription Economy R/A SGD-H","TLRY":"Tilray Inc.","IE00B3QW5Z07.USD":"GUINNESS GLOBAL MONEY MANAGERS \"C\" (USD) ACC","IE00BKPKM429.USD":"NEUBERGER BERMAN GLOBAL SUSTAINABLE EQUITY \"A\" (USD) ACC","LU2210150020.SGD":"Natixis Thematics Subscription Economy R/A SGD","LU2095319765.USD":"Natixis Thematics Subscription Economy R/A USD","BK4588":"碎股","NDAQ":"纳斯达克OMX交易所","BK4112":"金融交易所和数据","BK4557":"大麻股","IE00BGHQF748.EUR":"GUINNESS GLOBAL MONEY MANAGERS \"C\" (EUR) ACC"},"translate_title":"Tilray子公司FL Group与Molteni合作加强意大利医用大麻的获取","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"NDAQ":0.9,"TLRY":0.9},"content_text":"Tilray Subsidiary FL Group Partners with Molteni to Enhance Medical Cannabis Access in Italy\n    \n\n        Tilray Medical, a division of Tilray Brands, Inc., has announced a strategic partnership through its wholly-owned subsidiary, FL Group S.R.L., with L. Molteni & C. dei F.lli Alitti Società di Esercizio S.p.A., an Italian pharmaceutical company. This collaboration aims to expand access to medical cannabis extracts across Italy. By combining FL Group's regulatory and distribution capabilities with Molteni's scientific expertise, the partnership seeks to enhance the availability of EU-GMP certified cannabis therapies. Additionally, Molteni will leverage its extensive network of healthcare professionals to provide targeted education on medical cannabis therapies, emphasizing pain management solutions. Tilray Medical continues to be a leader in the European medical cannabis market, with operations in Germany, Italy, Portugal, Poland, and the United Kingdom.\n      \n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tilray Brands Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9510473-en) on August 13, 2025, and is solely responsible for the information contained therein.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[{"id":467371395985744,"gmtCreate":1755103749056,"gmtModify":1755104313890,"author":{"id":"3577767277931441","authorId":"3577767277931441","name":"K75","avatar":"https://community-static.tradeup.com/news/ef66fd8f683c910523c82bd7329b5e36","vip":1,"crmLevel":9,"crmLevelSwitch":0,"authorIdStr":"3577767277931441","idStr":"3577767277931441"},"htmlText":"Great article, would you like to share it?","listText":"Great article, would you like to share it?","text":"Great article, would you like to share it?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/467371395985744","repostId":2559609994,"repostType":2,"repost":{"id":"2559609994","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"pubTimestamp":1755082841,"share":"https://ttm.financial/m/news/2559609994?lang=en_US&edition=fundamental","pubTime":"2025-08-13 19:00","market":"fut","language":"en","title":"Tilray Subsidiary FL Group Partners with Molteni to Enhance Medical Cannabis Access in Italy","url":"https://stock-news.laohu8.com/highlight/detail?id=2559609994","media":"Reuters","summary":"Tilray Medical, a division of Tilray Brands, Inc., has announced a strategic partnership through its wholly-owned subsidiary, FL Group S.R.L., with L. Molteni & C. dei F.lli Alitti Società di Esercizio S.p.A., an Italian pharmaceutical company. This collaboration aims to expand access to medical cannabis extracts across Italy. By combining FL Group's regulatory and distribution capabilities with Molteni's scientific expertise, the partnership seeks to enhance the availability of EU-GMP certified cannabis therapies. Additionally, Molteni will leverage its extensive network of healthcare professionals to provide targeted education on medical cannabis therapies, emphasizing pain management solutions. Tilray Medical continues to be a leader in the European medical cannabis market, with operations in Germany, Italy, Portugal, Poland, and the United Kingdom.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide ","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      Tilray Subsidiary FL Group Partners with Molteni to Enhance Medical Cannabis Access in Italy\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Tilray Medical, a division of Tilray Brands, Inc., has announced a strategic partnership through its wholly-owned subsidiary, FL Group S.R.L., with L. Molteni &amp; C. dei F.lli Alitti Società di Esercizio S.p.A., an Italian pharmaceutical company. This collaboration aims to expand access to medical cannabis extracts across Italy. By combining FL Group's regulatory and distribution capabilities with Molteni's scientific expertise, the partnership seeks to enhance the availability of EU-GMP certified cannabis therapies. Additionally, Molteni will leverage its extensive network of healthcare professionals to provide targeted education on medical cannabis therapies, emphasizing pain management solutions. Tilray Medical continues to be a leader in the European medical cannabis market, with operations in Germany, Italy, Portugal, Poland, and the United Kingdom.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tilray Brands Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9510473-en) on August 13, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tilray Subsidiary FL Group Partners with Molteni to Enhance Medical Cannabis Access in Italy</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTilray Subsidiary FL Group Partners with Molteni to Enhance Medical Cannabis Access in Italy\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-08-13 19:00</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      Tilray Subsidiary FL Group Partners with Molteni to Enhance Medical Cannabis Access in Italy\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Tilray Medical, a division of Tilray Brands, Inc., has announced a strategic partnership through its wholly-owned subsidiary, FL Group S.R.L., with L. Molteni &amp; C. dei F.lli Alitti Società di Esercizio S.p.A., an Italian pharmaceutical company. This collaboration aims to expand access to medical cannabis extracts across Italy. By combining FL Group's regulatory and distribution capabilities with Molteni's scientific expertise, the partnership seeks to enhance the availability of EU-GMP certified cannabis therapies. Additionally, Molteni will leverage its extensive network of healthcare professionals to provide targeted education on medical cannabis therapies, emphasizing pain management solutions. Tilray Medical continues to be a leader in the European medical cannabis market, with operations in Germany, Italy, Portugal, Poland, and the United Kingdom.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tilray Brands Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9510473-en) on August 13, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4547":"WSB热门概念","LU0314104364.USD":"MANULIFE GF AMERICAN GROWTH \"AA\" (USD) INC","BK4585":"ETF&股票定投概念","IE00B64PRP62.GBP":"GUINNESS GLOBAL MONEY MANAGERS \"C\" (GBP) ACC","BK4596":"哈里斯概念","BK4007":"制药","LU2210149790.SGD":"Natixis Thematics Subscription Economy R/A SGD-H","TLRY":"Tilray Inc.","IE00B3QW5Z07.USD":"GUINNESS GLOBAL MONEY MANAGERS \"C\" (USD) ACC","IE00BKPKM429.USD":"NEUBERGER BERMAN GLOBAL SUSTAINABLE EQUITY \"A\" (USD) ACC","LU2210150020.SGD":"Natixis Thematics Subscription Economy R/A SGD","LU2095319765.USD":"Natixis Thematics Subscription Economy R/A USD","BK4588":"碎股","NDAQ":"纳斯达克OMX交易所","BK4112":"金融交易所和数据","BK4557":"大麻股","IE00BGHQF748.EUR":"GUINNESS GLOBAL MONEY MANAGERS \"C\" (EUR) ACC"},"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250813:nNDL9PqKr:1","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2559609994","content_text":"Tilray Subsidiary FL Group Partners with Molteni to Enhance Medical Cannabis Access in Italy\n    \n\n        Tilray Medical, a division of Tilray Brands, Inc., has announced a strategic partnership through its wholly-owned subsidiary, FL Group S.R.L., with L. Molteni & C. dei F.lli Alitti Società di Esercizio S.p.A., an Italian pharmaceutical company. This collaboration aims to expand access to medical cannabis extracts across Italy. By combining FL Group's regulatory and distribution capabilities with Molteni's scientific expertise, the partnership seeks to enhance the availability of EU-GMP certified cannabis therapies. Additionally, Molteni will leverage its extensive network of healthcare professionals to provide targeted education on medical cannabis therapies, emphasizing pain management solutions. Tilray Medical continues to be a leader in the European medical cannabis market, with operations in Germany, Italy, Portugal, Poland, and the United Kingdom.\n      \n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tilray Brands Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9510473-en) on August 13, 2025, and is solely responsible for the information contained therein.","news_type":1,"symbols_score_info":{"NDAQ":0.9,"TLRY":0.9}},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"}],"isCommentEnd":false,"newsSizeData":{"likeSize":0,"commentSize":1,"repostSize":1,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2559609994","isCrawlerRequest":true}